
π Pharma & Life Sciences Β· Sequence
How a suspected side effect reported by a doctor or patient is captured, assessed and reported to the regulator on time (pharmacovigilance).
Drawing diagramβ¦
Pharmacovigilance sequence: a doctor reports a suspected adverse drug reaction through the company portal, the safety database creates a case, a safety associate checks for duplicates and requests missing follow-up information, a medical reviewer assesses seriousness and causality, serious unexpected cases are submitted to the regulator (e.g. CDSCO / FDA) as an electronic ICSR within 15 days, and the case is included in periodic safety reports.
sequenceDiagram
actor Dr as Doctor
participant Portal as Safety Portal
participant DB as Safety Database
participant SA as Safety Associate
participant MR as Medical Reviewer
participant Reg as Regulator
Dr->>Portal: Report suspected reaction
Portal->>DB: Create case (Day 0)
DB->>SA: New case
SA->>SA: Check duplicates
SA->>Dr: Request follow-up details
Dr-->>SA: Lab values, outcome
SA->>MR: Case ready for review
MR->>MR: Assess seriousness and causality
alt Serious and unexpected
MR->>Reg: E2B ICSR within 15 days
Reg-->>MR: Acknowledged
else Non-serious
MR->>DB: Include in periodic report
endThe states of a laboratory sample in a LIMS, from collection to reporting and disposal, with rejection and re-testing.
The systems that run a clinical trial: trial management, electronic data capture, randomisation, drug supply and safety reporting.
How medicine packs are serialised and traced from factory to pharmacy to stop counterfeits: unique codes, aggregation and verification.
How a pharmaceutical company prepares and files a marketing application (dossier) with regulators and handles their queries.
A schema for electronic batch records in pharmaceutical manufacturing: products, master recipes, batches, steps, materials used and deviations.
How a pharmaceutical plant handles a manufacturing deviation: report, impact assessment, root cause, CAPA and batch disposition.